Skip to main content
. 2017 May;14(2):142–150. doi: 10.20892/j.issn.2095-3941.2016.0091

2.

2

Promega system results and IHC for MSH6-deficient patient. Stability in tumor tissue (A) compared with normal tissue (B). IHC staining demonstrating loss of MSH6 expression in the patient (C) (10 ×).